Cancer Intervention Surveillance Modeling Network (CISNET)
Digital breast tomosynthesis (DBT)
Odds ratio (OR)
Definitions
Overdiagnosis: Screen detection of cancers that would not have become clinically apparent during patient's lifetime
Sojourn time: Time between cancer development and clinical presentation of physical signs or symptoms of disease
Lead time: Time between cancer detection by imaging screening vs. when it would have been detected clinically
Interval cancer: Cancer diagnosed because of symptoms during interval between recommended screening exams
e.g., within 1 year of screening in USA, or within 2 years in Europe, 3 in United Kingdom
Recall rate: Percent of screening exams recommended for additional imaging (i.e., BI-RADS 0 assessment)
IMAGING
Imaging Recommendations
CLINICAL ISSUES
Demographics
Natural History & Prognosis
Treatment
Selected References
Ahn S et al: Impact of screening mammography on treatment in women diagnosed with breast cancer. Ann Surg Oncol. 25(10):2979-2986, 2018
Carter KJ et al: Insights into breast cancer screening: a computer simulation of two contemporary screening strategies. AJR Am J Roentgenol. 210(3):564-571, 2018
Destounis S et al: Age to begin and intervals for breast cancer screening: balancing benefits and harms. AJR Am J Roentgenol. 210(2):279-284, 2018
Lee CS et al: Harmonizing breast cancer screening recommendations: metrics and accountability. AJR Am J Roentgenol. 210(2):241-245, 2018
Narayan AK et al: Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines. Breast Cancer Res Treat. 172(2):463-468, 2018
Patel SB: Estimated mortality of breast cancer patients based on stage at diagnosis and national screening guideline categorization. J Am Coll Radiol. 15(9):1206-1213, 2018
Arleo EK et al: Comparison of recommendations for screening mammography using CISNET models. Cancer. 123(19):3673-3680, 2017
Arleo EK et al: Persistent untreated screening-detected breast cancer: an argument against delaying screening or increasing the interval between screenings. J Am Coll Radiol. 14(7):863-867, 2017
Eby PR: Evidence to support screening women annually. Radiol Clin North Am. 55(3):441-456, 2017
Monticciolo DL et al: Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 14(9):1137-1143, 2017
Mandelblatt JS et al: Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies. Ann Intern Med. 164(4):215-25, 2016
Miglioretti DL et al: Radiation-induced breast cancer incidence and mortality from digital mammography screening: a modeling study. Ann Intern Med. 164(4):205-14, 2016
Nelson HD et al: Harms of breast cancer screening: systematic review to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 164(4):256-67, 2016
Siu AL et al: Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 164(4):279-96, 2016
Engel JM et al: All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol. 204(4):898-902, 2015
Miglioretti DL et al: Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status. JAMA Oncol. 1(8):1069-77, 2015
Oeffinger KC et al: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 314(15):1599-614, 2015
Sanderson M et al: Mammography screening among the elderly: a research challenge. Am J Med. 128(12):1362.e7-14, 2015
Winch CJ et al: Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50. Breast Cancer Res Treat. 149(1):211-21, 2015
Yaffe MJ et al: Clinical outcomes of modelling mammography screening strategies. Health Rep. 26(12):9-15, 2015
Webb ML et al: A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer. 120(18):2839-46, 2014
Kerlikowske K et al: Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 173(9):807-16, 2013
O'Meara ES et al: Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 119(22):3959-67, 2013
Hendrick RE et al: United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 196(2):W112-6, 2011
Wu JC et al: Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer. Breast Cancer Res Treat. 122(2):553-66, 2010
Mandelblatt JS et al: Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 151(10):738-47, 2009
Randall D et al: Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia. Cancer Causes Control. 20(5):559-66, 2009
White E et al: Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 96(24):1832-9, 2004
Carlson KL et al: Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ. AJR Am J Roentgenol. 172(2):313-7, 1999
Hunt KA et al: Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations. AJR Am J Roentgenol. 173(2):285-9, 1999
Michaelson JS et al: Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology. 212(2):551-60, 1999
Feig SA et al: Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 119-24, 1997
Moskowitz M: Breast cancer: age-specific growth rates and screening strategies. Radiology. 161(1):37-41, 1986
Related Anatomy
Loading...
Related Differential Diagnoses
Loading...
References
Tables
Tables
KEY FACTS
Imaging
Clinical Issues
TERMINOLOGY
Abbreviations
National Mammography Database (NMD)
Breast Cancer Surveillance Consortium (BCSC)
American College of Radiology (ACR)
Cancer Intervention Surveillance Modeling Network (CISNET)
Digital breast tomosynthesis (DBT)
Odds ratio (OR)
Definitions
Overdiagnosis: Screen detection of cancers that would not have become clinically apparent during patient's lifetime
Sojourn time: Time between cancer development and clinical presentation of physical signs or symptoms of disease
Lead time: Time between cancer detection by imaging screening vs. when it would have been detected clinically
Interval cancer: Cancer diagnosed because of symptoms during interval between recommended screening exams
e.g., within 1 year of screening in USA, or within 2 years in Europe, 3 in United Kingdom
Recall rate: Percent of screening exams recommended for additional imaging (i.e., BI-RADS 0 assessment)
IMAGING
Imaging Recommendations
CLINICAL ISSUES
Demographics
Natural History & Prognosis
Treatment
Selected References
Ahn S et al: Impact of screening mammography on treatment in women diagnosed with breast cancer. Ann Surg Oncol. 25(10):2979-2986, 2018
Carter KJ et al: Insights into breast cancer screening: a computer simulation of two contemporary screening strategies. AJR Am J Roentgenol. 210(3):564-571, 2018
Destounis S et al: Age to begin and intervals for breast cancer screening: balancing benefits and harms. AJR Am J Roentgenol. 210(2):279-284, 2018
Lee CS et al: Harmonizing breast cancer screening recommendations: metrics and accountability. AJR Am J Roentgenol. 210(2):241-245, 2018
Narayan AK et al: Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines. Breast Cancer Res Treat. 172(2):463-468, 2018
Patel SB: Estimated mortality of breast cancer patients based on stage at diagnosis and national screening guideline categorization. J Am Coll Radiol. 15(9):1206-1213, 2018
Arleo EK et al: Comparison of recommendations for screening mammography using CISNET models. Cancer. 123(19):3673-3680, 2017
Arleo EK et al: Persistent untreated screening-detected breast cancer: an argument against delaying screening or increasing the interval between screenings. J Am Coll Radiol. 14(7):863-867, 2017
Eby PR: Evidence to support screening women annually. Radiol Clin North Am. 55(3):441-456, 2017
Monticciolo DL et al: Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 14(9):1137-1143, 2017
Mandelblatt JS et al: Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies. Ann Intern Med. 164(4):215-25, 2016
Miglioretti DL et al: Radiation-induced breast cancer incidence and mortality from digital mammography screening: a modeling study. Ann Intern Med. 164(4):205-14, 2016
Nelson HD et al: Harms of breast cancer screening: systematic review to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 164(4):256-67, 2016
Siu AL et al: Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 164(4):279-96, 2016
Engel JM et al: All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol. 204(4):898-902, 2015
Miglioretti DL et al: Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status. JAMA Oncol. 1(8):1069-77, 2015
Oeffinger KC et al: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 314(15):1599-614, 2015
Sanderson M et al: Mammography screening among the elderly: a research challenge. Am J Med. 128(12):1362.e7-14, 2015
Winch CJ et al: Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50. Breast Cancer Res Treat. 149(1):211-21, 2015
Yaffe MJ et al: Clinical outcomes of modelling mammography screening strategies. Health Rep. 26(12):9-15, 2015
Webb ML et al: A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer. 120(18):2839-46, 2014
Kerlikowske K et al: Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 173(9):807-16, 2013
O'Meara ES et al: Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 119(22):3959-67, 2013
Hendrick RE et al: United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 196(2):W112-6, 2011
Wu JC et al: Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer. Breast Cancer Res Treat. 122(2):553-66, 2010
Mandelblatt JS et al: Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 151(10):738-47, 2009
Randall D et al: Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia. Cancer Causes Control. 20(5):559-66, 2009
White E et al: Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 96(24):1832-9, 2004
Carlson KL et al: Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ. AJR Am J Roentgenol. 172(2):313-7, 1999
Hunt KA et al: Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations. AJR Am J Roentgenol. 173(2):285-9, 1999
Michaelson JS et al: Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology. 212(2):551-60, 1999
Feig SA et al: Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 119-24, 1997
Moskowitz M: Breast cancer: age-specific growth rates and screening strategies. Radiology. 161(1):37-41, 1986
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.